Impact of Point-Spread Function Reconstruction on 68Ga-DOTATATE PET/CT Quantitative Imaging Parameters

被引:3
|
作者
You, Helena [1 ]
Sanli, Yasemin [1 ]
Subramaniam, Rathan M. [1 ,2 ,3 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
关键词
Ga-68-DOTATATE; neuroendocrine tumors; PET/CT; point-spread function; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; TIME-OF-FLIGHT; NEUROENDOCRINE TUMORS; F-18-FDG PET/CT; MANAGEMENT; HETEROGENEITY; DIAGNOSIS; IN-111-DTPA-OCTREOTIDE; DOSIMETRY;
D O I
10.2214/AJR.18.21067
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the impact of point-spread function (PSI) reconstruction and lesion size on Ga-68-tetraazacyclododecanetetraacetic acid-DPhel-Tyr3-octreotate (DOTATATE) PET/CT quantitative parameters. MATERIALS AND METHODS. A total of 38 patients with 42 Ga-68-DOATATE PET/CT studies and 125 lesions were included. Scans were reconstructed with and without PSF modulation. For each lesion, the maximum standardized uptake value (SUVmax) and peak standardized uptake value (SUVpeak), metabolic tumor volume (MTV), total lesion somatostatin avidity, and tumor somatostatin receptor expression heterogeneity using the AUC method were measured. Intraclass correlation coefficient (ICC) and Bland-Altman analyses were used to compare PSF and non-PSF values. A subgroup analysis was performed to determine the impact of lesion size. RESULTS. Of the 125 lesions, 51 were in the liver, 31 in lymph nodes, 17 in bone, eight in pancreas, four in lung, and 14 in other sites. The ICCs between PSF and non-PSF values were excellent for SUVmax, SUVpeak, MTV, and total lesion somatostatin avidity (ICC = 0.97-0.99), and the ICC was good for tumor somatostatin receptor expression heterogeneity (ICC = 0.81). Comparison of PSF with non-PSF values showed a bias (mean percentage change +/- SD) of 27.5% +/- 14.7% for SUVmax, 15.5% +/- 9.5% for SUVpeak, -18.6% +/- 37.6% for MTV, 0.8% +/- 28.1% for total lesion somatostatin avidity, and -7.1% +/- 11.0% for tumor somatostatin receptor expression heterogeneity. Comparison of PSF with non-PSF values for lesions less than 2 cm (n = 75) showed corresponding biases greater than those for lesions 2 cm or larger (n = 50). CONCLUSION. PSF reconstruction effected higher values for SUVmax and SUVpeak, produced decreased values for tumor somatostatin receptor expression heterogeneity, and had a variable effect on MTV and total lesion somatostatin avidity depending on lesion size.
引用
收藏
页码:683 / 688
页数:6
相关论文
共 50 条
  • [21] Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented
    Calais, Jeremie
    Czernin, Johannes
    Eiber, Matthias
    Fendler, Wolfgang P.
    Gartmann, Jeannine
    Heaney, Anthony P.
    Hendifar, Andrew E.
    Pisegna, Joseph R.
    Hecht, J. Randolph
    Wolin, Edward M.
    Slavik, Roger
    Gupta, Pawan
    Quon, Andrew
    Schiepers, Christiaan
    Allen-Auerbach, Martin S.
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (11) : 1793 - 1796
  • [22] Sacral Insufficiency Fracture on 68Ga-DOTATATE PET/CT
    Filizoglu, Nuh
    Bugdayci, Onur
    Ozguven, Salih
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (10) : E490 - E491
  • [23] 68Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine Tumor
    Metser, Ur
    Ezzat, Shereen
    Singh, Simron
    Myrehaug, Sten
    Rahimi, Shiva
    Gray, Daryl
    Singnurkar, Amit
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (11) : 933 - 936
  • [24] 68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
    Poeppel, Thorsten D.
    Binse, Ina
    Petersenn, Stephan
    Lahner, Harald
    Schott, Matthias
    Antoch, Gerald
    Brandau, Wolfgang
    Bockisch, Andreas
    Boy, Christian
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (12) : 1864 - 1870
  • [25] Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Wild, Damian
    Bomanji, Jamshed B.
    Benkert, Pascal
    Maecke, Helmut
    Ell, Peter J.
    Reubi, Jean Claude
    Caplin, Martyn E.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (03) : 364 - 372
  • [26] Improvement in PET/CT Image Quality with a Combination of Point-Spread Function and Time-of-Flight in Relation to Reconstruction Parameters
    Akamatsu, Go
    Ishikawa, Kaori
    Mitsumoto, Katsuhiko
    Taniguchi, Takafumi
    Ohya, Nobuyoshi
    Baba, Shingo
    Abe, Koichiro
    Sasaki, Masayuki
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (11) : 1716 - 1722
  • [27] Impact of 68Ga-DOTATATE PET/CT on the Surgical Management of Primary Neuroendocrine Tumors of the Pancreas or Ileum
    Ilhan, Harun
    Fendler, Wolfgang P.
    Cyran, Clemens C.
    Spitzweg, Christine
    Auernhammer, Christoph J.
    Gildehaus, Franz-Josef
    Bartenstein, Peter
    Angele, Martin K.
    Haug, Alexander R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (01) : 164 - 171
  • [28] Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
    Herrmann, Ken
    Czernin, Johannes
    Wolin, Edward M.
    Gupta, Pawan
    Barrio, Martin
    Gutierrez, Antonio
    Schiepers, Christiaan
    Mosessian, Sherly
    Phelps, Michael E.
    Allen-Auerbach, Martin S.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01) : 70 - 75
  • [29] 68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
    Chang, Chian A.
    Pattison, David A.
    Tothill, Richard W.
    Kong, Grace
    Akhurst, Tim J.
    Hicks, Rodney J.
    Hofman, Michael S.
    CANCER IMAGING, 2016, 16
  • [30] Neuroendocrine Tumor Recurrence: Diagnosis with 68Ga-DOTATATE PET/CT
    Haug, Alexander R.
    Cindea-Drimus, Ramona
    Auernhammer, Christoph J.
    Reincke, Martin
    Beuschlein, Felix
    Waengler, Bjoern
    Uebleis, Christopher
    Schmidt, Gerwin P.
    Spitzweg, Christine
    Bartenstein, Peter
    Hacker, Marcus
    RADIOLOGY, 2014, 270 (02) : 517 - 525